| Patent | Date |
|---|
Compositions And Methods For The Treatment Or Prevention Of Mitochondrial Diseases
App 20120277286 - Youle; Richard J. ; et al. | 2012-11-01 |
Methods and Compositions for Inhibiting Cell Death or Enhacing Cell Proliferation
App 20100317577 - Youle; Richard J ; et al. | 2010-12-16 |
Receptor-mediated Uptake Of An Extracellular Bcl-xl Fusion Protein Inhibits Apoptosis
App 20090075882 - Youle; Richard J. ; et al. | 2009-03-19 |
Receptor-mediated Uptake Of An Extracellular Bcl-xl Fusion Protein Inhibits Apoptosis
App 20070243190 - Youle; Richard J. ; et al. | 2007-10-18 |
Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
App 20050266010 - Hott, Jonathan S. ; et al. | 2005-12-01 |
Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
Grant 6,780,413 - Hott , et al. August 24, 2 | 2004-08-24 |
Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosis
App 20040152179 - Youle, Richard J. ; et al. | 2004-08-05 |
Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
Grant 6,737,511 - Youle , et al. May 18, 2 | 2004-05-18 |
Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy
Grant 6,696,064 - Youle , et al. February 24, 2 | 2004-02-24 |
Mutant form of a cytotoxic ribonucleolytic protein which allows production by recombinant methods
Grant 6,649,392 - Youle , et al. November 18, 2 | 2003-11-18 |
Mutant form of cytotoxic ribonucleolytic protein which allows production by recombinant methods
Grant 6,649,393 - Youle , et al. November 18, 2 | 2003-11-18 |
Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
App 20020081303 - Hott, Jonathan S. ; et al. | 2002-06-27 |
Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy
App 20020016335 - Youle, Richard J. ; et al. | 2002-02-07 |
Selective RNase cytotoxic reagents
Grant 5,955,073 - Rybak , et al. September 21, 1 | 1999-09-21 |
Selective RNase cytotoxic reagents
Grant 5,840,840 - Rybak , et al. November 24, 1 | 1998-11-24 |
Mutant diphtheria toxin conjugates
Grant 5,792,458 - Johnson , et al. August 11, 1 | 1998-08-11 |
Treatment of tumors of the central nervous system with immunotoxins
Grant 5,728,383 - Johnson , et al. March 17, 1 | 1998-03-17 |
Immunotoxins for treatment of intracranial lesions and as adjunct to chemotherapy
Grant 5,352,447 - Johnson , et al. October 4, 1 | 1994-10-04 |
Method of preparing diphtheria immunotoxins
Grant 5,208,021 - Johnson , et al. May 4, 1 | 1993-05-04 |
Inactivating protein synthesis by incubating anti-Thy 1.1-ricin a chain monoclonal antibody hybrids with target protein cells
Grant 4,520,011 - Neville, Jr. , et al. May 28, 1 | 1985-05-28 |
Treatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: ricin conjugates
Grant 4,520,226 - Neville, Jr. , et al. May 28, 1 | 1985-05-28 |
Monoclonal antibody-ricin hybrids as a treatment of murine graft-versus-host disease
Grant 4,440,747 - Neville Jr. , et al. April 3, 1 | 1984-04-03 |
Mannose-6-phosphate-low density protein reagent effective against hypercholesterolemia
Grant 4,397,843 - Neville, Jr. , et al. August 9, 1 | 1983-08-09 |
Anti Thy 1.2 monoclonal antibody-ricin hybrid utilized as a tumor suppressant
Grant 4,359,457 - Neville, Jr. , et al. November 16, 1 | 1982-11-16 |
| 